Found 9 matching trials
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant PHASE1 RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers PHASE2 Background:
Patients with cancers of the blood and immune system often ben...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT PHASE2 This study evaluates the efficacy of high-dose post-transplantation cycloph...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Stem Cell Transplantation for Patients With Hematologic Malignancies PHASE3 Childhood leukemias which cannot be cured by chemotherapy alone may be effe...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance PHASE2 The primary objective of this study is to assess the ability of bone marrow...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) PHASE3 The study is designed as a three arm randomized Phase III, multicenter tria...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies PHASE2 This is a multi-institutional phase II haploidentical T cell replete bone m...
Show More Location
Children's Hospital of Colorado
Learn More & Join Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant PHASE2 This phase II trial studies how well naive T-cell depletion works in preven...
Show More Location
Children's Hospital of Los Angeles
Learn More & Join Trial
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis PHASE1 This is a Phase I, single arm, open label, single center pilot study to ass...
Show More Location
Johns Hopkins University
Learn More & Join Trial